“Deucravacitinib Improves Psoriasis Symptoms and Signs Diary Domain Scores in Patients With Moderate to Severe Plaque Psoriasis: Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Studies”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s38. Accessed May 17, 2025. https://skin.dermsquared.com/skin/article/view/1389.